X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 65 filers reported holding X4 PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,612 | -62.7% | 27,167 | -33.7% | 0.00% | – |
Q2 2023 | $79,455 | -62.7% | 40,956 | +65.9% | 0.00% | – |
Q1 2021 | $213,000 | +41.1% | 24,681 | +4.8% | 0.00% | – |
Q4 2020 | $151,000 | -5.0% | 23,541 | 0.0% | 0.00% | – |
Q3 2020 | $159,000 | -27.4% | 23,541 | +0.4% | 0.00% | – |
Q2 2020 | $219,000 | -6.4% | 23,445 | 0.0% | 0.00% | -100.0% |
Q1 2020 | $234,000 | +21.2% | 23,445 | +30.1% | 0.00% | – |
Q4 2019 | $193,000 | -17.9% | 18,027 | -2.5% | 0.00% | – |
Q3 2019 | $235,000 | +46.0% | 18,495 | +72.1% | 0.00% | – |
Q2 2019 | $161,000 | +666.7% | 10,748 | +811.6% | 0.00% | – |
Q1 2019 | $21,000 | – | 1,179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 311,490 | $532,000 | 1.65% |
Bain Capital Life Sciences Investors, LLC | 6,389,436 | $10,926,000 | 1.30% |
Tri Locum Partners LP | 2,504,006 | $4,282,000 | 1.18% |
Sio Capital Management, LLC | 1,418,461 | $2,426,000 | 0.77% |
NEA Management Company, LLC | 6,523,157 | $11,155,000 | 0.56% |
AIGH Capital Management LLC | 997,719 | $1,706,000 | 0.53% |
Parkman Healthcare Partners LLC | 950,000 | $1,625,000 | 0.46% |
New Leaf Venture Partners, L.L.C. | 335,000 | $573,000 | 0.34% |
Worth Venture Partners, LLC | 250,144 | $428,000 | 0.26% |
Ikarian Capital, LLC | 568,612 | $973,000 | 0.19% |